Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection

Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction caused by the fungus Aspergillus, and it is often treated with steroids or antifungal agents. However, long-term use of these medications can lead to infections and drug interactions. We present the case of a 71-year-old woman wi...

Full description

Bibliographic Details
Main Authors: Toru Hamada, Tomoya Katsuta, Kento Aibara, Shohei Nozu, Junya Nakamura, Haruka Kondo, Sayaka Tachibana, Koji Inoue, Norihiko Nakanishi, Tomonori Moritaka
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007123000850
_version_ 1797770820112613376
author Toru Hamada
Tomoya Katsuta
Kento Aibara
Shohei Nozu
Junya Nakamura
Haruka Kondo
Sayaka Tachibana
Koji Inoue
Norihiko Nakanishi
Tomonori Moritaka
author_facet Toru Hamada
Tomoya Katsuta
Kento Aibara
Shohei Nozu
Junya Nakamura
Haruka Kondo
Sayaka Tachibana
Koji Inoue
Norihiko Nakanishi
Tomonori Moritaka
author_sort Toru Hamada
collection DOAJ
description Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction caused by the fungus Aspergillus, and it is often treated with steroids or antifungal agents. However, long-term use of these medications can lead to infections and drug interactions. We present the case of a 71-year-old woman with ABPA who was diagnosed with hepatitis B and active hepatitis C, and sputum analysis revealed the presence of bacteria. Oral steroids were initially administered, but the patient was switched to mepolizumab because of numerous infectious complications. The early introduction of mepolizumab is effective in patients with ABPA complicated by infectious diseases.
first_indexed 2024-03-12T21:27:39Z
format Article
id doaj.art-66e08f9681474634b47b9485709fcf23
institution Directory Open Access Journal
issn 2213-0071
language English
last_indexed 2024-03-12T21:27:39Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Respiratory Medicine Case Reports
spelling doaj.art-66e08f9681474634b47b9485709fcf232023-07-28T04:25:59ZengElsevierRespiratory Medicine Case Reports2213-00712023-01-0145101890Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infectionToru Hamada0Tomoya Katsuta1Kento Aibara2Shohei Nozu3Junya Nakamura4Haruka Kondo5Sayaka Tachibana6Koji Inoue7Norihiko Nakanishi8Tomonori Moritaka9Corresponding author. Seiyo Municipal Hospital, Seiyo, Ehime, 797-0029, Japan.; Respiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanRespiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanRespiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanRespiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanRespiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanRespiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanRespiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanRespiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanRespiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanRespiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, JapanAllergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction caused by the fungus Aspergillus, and it is often treated with steroids or antifungal agents. However, long-term use of these medications can lead to infections and drug interactions. We present the case of a 71-year-old woman with ABPA who was diagnosed with hepatitis B and active hepatitis C, and sputum analysis revealed the presence of bacteria. Oral steroids were initially administered, but the patient was switched to mepolizumab because of numerous infectious complications. The early introduction of mepolizumab is effective in patients with ABPA complicated by infectious diseases.http://www.sciencedirect.com/science/article/pii/S2213007123000850Allergic bronchial aspergillosisMepolizumabNumerous infectious complications
spellingShingle Toru Hamada
Tomoya Katsuta
Kento Aibara
Shohei Nozu
Junya Nakamura
Haruka Kondo
Sayaka Tachibana
Koji Inoue
Norihiko Nakanishi
Tomonori Moritaka
Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
Respiratory Medicine Case Reports
Allergic bronchial aspergillosis
Mepolizumab
Numerous infectious complications
title Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
title_full Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
title_fullStr Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
title_full_unstemmed Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
title_short Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
title_sort mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
topic Allergic bronchial aspergillosis
Mepolizumab
Numerous infectious complications
url http://www.sciencedirect.com/science/article/pii/S2213007123000850
work_keys_str_mv AT toruhamada mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection
AT tomoyakatsuta mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection
AT kentoaibara mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection
AT shoheinozu mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection
AT junyanakamura mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection
AT harukakondo mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection
AT sayakatachibana mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection
AT kojiinoue mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection
AT norihikonakanishi mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection
AT tomonorimoritaka mepolizumabinallergicbronchopulmonaryaspergillosiscomplicatedbyinfection